FRONTIERS IN PSYCHEDELIC SCIENCE

This transdisciplinary seminar brings together experts from different fields such as neuroscience, psychology & psychotherapy, philosophy and consciousness research to advance the critical dialogue about recent developments and future directions in psychedelic research.

Public lectures by invited speakers will be complemented by plenary discussions.

This seminar is hosted by the Psychedelic Research & Therapy Development group at the University of Zurich and the Reconnect Foundation.

To receive updates, subscribe for our newsletter.


Ästhetische Aufmerksamkeit und die psychedelische Erfahrung

Monday, December 6, 2021, 18:30 - 19:45, University of Zurich

Ass.-Prof. Dr. Susanne Schmetkamp
SNSF PRIMA Research Group Leader „Aesthetics and Ethics of Attention“, University of Fribourg

Please note: In line with the current regulations of the BAG, a certificate (Covid-19) is required for public events at the University of Zurich.

Psychedelic world-making. What psychedelics can teach us about cognition and perception. An enactive cognitive science perspective in comparison with buddhist philosophy

Monday, November 8, 2021, 18:30 - 19:45, University of Zurich

Daniel Meling, MSc, cand. PhD
Psychedelic Research and Therapy Development, University of Zurich

Please note: In line with the current regulations of the BAG, a certificate (Covid-19) is required for public events at the University of Zurich.

Neural emotion- and self-processing with psychedelics

Monday, October 4, 2021, 18:30 - 19:45, University of Zurich, KOL-F-118

Prof. Uwe Herwig
Medical Director at the Center for Psychiatry Reichenau, Germany

The presentation focuses on neural correlates of emotion- and self-regulation in healthy subjects and in people with mental disorders under the influence of psychedelics. In this field of research, particularly neuroimaging provided important results. Hereby, modulations of for instance amygdala activity, in brain regions of self-reference, and of the default mode network were described during and after intake of Psilocybin, LSD, Ayahuasca and MDMA. Possible modes of integral neuro-psychotherapeutic effects will be derived.

Prof. Uwe Herwig is Medical Director at the Center for Psychiatry Reichenau, academic hospital of the University of Konstanz, Germany. He founded and headed for years the research group for emotion regulation at the University Hospital for Psychiatry Zurich, also with contact to the research with psychedelic substances. He obtained doctoral degrees from the Universities of Göttingen and ETH Zurich, and he teaches at the Universities of Konstanz, Ulm and Zurich.

Please note: In line with the current regulations of the BAG, a certificate (Covid-19) is required for public events at the University of Zurich.